chemotherapy/breast neoplasms

TECHNICAL FIELD The present invention relates to methods, kits and systems for predicting the benefit from inclusion of taxane in a chemotherapy regimen based on the measurements of gene expression levels in tumor samples of breast cancer patients. BACKGROUND OF THE INVENTION Breast cancer is the

FIELD OF THE INVENTION The invention relates to a method of image registration for assessing chemotherapy treatment response and early detection. More specifically, this invention relates to an image registration of longitudinal infrared images accepting MIR (middle-wave Infra-red) and LIR

FIELD OF THE INVENTION The present invention relates to quantitative molecular indicators that can guide clinical decisions in breast cancer, such as estrogen receptor (ESR1)-positive, lymph node-negative breast cancer. In particular, the invention concerns certain genes, the varied expression of

BACKGROUND 1. Technical Field This document relates to methods and materials involved in assessing chemotherapy responsiveness and treating cancer (e.g., breast cancer). For example, this document provides methods and materials for determining whether or not a cancer patient (e.g., a breast cancer

BACKGROUND OF THE INVENTION A. Field of the Invention The invention generally relates to the field of medicine. More particularly, it concerns the use of dendritic cell vaccines in immunotherapy of breast cancer. In certain aspects, the dendritic cells display cyclin B1 and WT-1 peptide epitopes and

FIELD OF THE INVENTION The present invention provides gene expression information useful for predicting whether cancer patients are likely to have a beneficial response to treatment response with chemotherapy. DESCRIPTION OF THE RELATED ART Gene Expression Studies Oncologists have a number of

FIELD OF THE INVENTION The present invention provides gene expression information useful for predicting whether cancer patients are likely to have a beneficial response to treatment response with chemotherapy. DESCRIPTION OF THE RELATED ART Gene Expression Studies Oncologists have a number of

BACKGROUND 1. Technical Field This document provides methods and materials related to using inhibitors of IL-9 signaling in conjunction with chemotherapy to treat cancer (e.g., solid tumors). For example, this document provides methods and materials for using inhibitors of IL-9 signaling (e.g.,

BACKGROUND 1. Technical Field This document provides methods and materials related to using inhibitors of IL-9 signaling in conjunction with chemotherapy to treat cancer (e.g., solid tumors). For example, this document provides methods and materials for using inhibitors of IL-9 signaling (e.g.,

CROSS-REFERENCE TO RELATED APPLICATIONS This Application is a U.S. National Stage Application of PCT/GB2013/050794 filed Mar. 27, 2013 which is incorporated by reference in its entirety. The invention relates to a method of identifying aggressive breast cancer tumours by considering the HAGE

BACKGROUND OF THE INVENTION 1. Field of the Invention The present method relates to determination of the portion of the breast cancer genome common to many patients with normal inheritance and expression patterns for targeting pharmaceutical treatments. The method identifies drug targets for

INCORPORATION OF SEQUENCE LISTING This application includes a Sequence Listing submitted via EFS-Web on Aug. 25, 2009, as a computer-readable form file entitled "SequenceListing.txt" (32 KB) dated Aug. 12, 2009. Which is hereby incorporated herein by reference it its entirety. FIELD OF THE

FIELD OF THE INVENTION The invention relates to a mechanism of quantitative dual-spectrum IR imaging system for breast cancer. More specifically, this invention relates to an image system with MIR (middle-wave Infra-red) and LIR (long-wave Infra-red) cameras for accepting longitudinal infrared

FIELD OF INVENTION The present disclosure describes methods of treating triple-negative breast cancer using thienotriazolodiazepine compounds which have improved solubility and bioavailability and may be provided in the form of solid dispersions. BACKGROUND OF THE INVENTION The compound of Formula

TECHNICAL FIELD The claimed methods relate to biomarkers of breast cancer and methods of use thereof. BACKGROUND Breast carcinomas represent a heterogeneous group of tumors at the clinical, histopathologic, and molecular levels (Cancer Genome Atlas Network, Nature 490:61-70, 2012). The diversity of